Cardinal Health Inc. buy UBS Group AG
Start price
29.01.24
/
50%
€98.14
Target price
29.01.25
€112.87
Performance (%)
-5.91%
Price
03.05.24
€91.88
Summary
This prediction is currently active. With a performance of -5.91%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. Dividends of €0.46 are taken into consideration when calculating the performance. This prediction currently runs until 29.01.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cardinal Health Inc. | -4.748% | -4.748% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by UBS_Group_AG for this prediction
In the thread Cardinal Health Inc. diskutieren
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at UBS Group AG from $114.00 to $122.00. They now have a "buy" rating on the stock.
Ratings data for CAH provided by MarketBeat
Stopped prediction by UBS_Group_AG for Cardinal Health Inc.
Cardinal Health Inc.
Start price
Target price
Perf. (%)
€96.44
05.02.24
05.02.24
€116.35
05.02.25
05.02.25
-4.25%
03.05.24
03.05.24